Globus Medical (GMED) Misses Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts GMED Hot Sheet
Join SI Premium – FREE
Globus Medical (NYSE: GMED) reported Q4 EPS of $0.31, $0.02 worse than the analyst estimate of $0.33. Revenue for the quarter came in at $151.6 million versus the consensus estimate of $149.3 million.
GUIDANCE:
Globus Medical sees FY2017 EPS of $1.27, versus the consensus of $1.27. Globus Medical sees FY2017 revenue of $625 million, versus the consensus of $624 million.
For earnings history and earnings-related data on Globus Medical (GMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Orion Marine Group (ORN) Tops Q3 EPS by 3c ; Offers Guidance
- Sound Finl Bancorp (SFBC) Tops Q3 EPS by 90c
- NOV Inc (NOV) Reports In-Line Q3 EPS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
